Cumberland Pharmaceuticals
CPIX
30 hedge funds and large institutions have $13.8M invested in Cumberland Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
15% more funds holding
Funds holding: 26 → 30 (+4)
3.6% less ownership
Funds ownership: 30.8% → 27.2% (-3.6%)
19% less capital invested
Capital invested by funds: $17M → $13.8M (-$3.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$465K |
| 2 |
BlackRock
New York
|
+$108K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$47.4K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$36.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.1M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$840K |
| 3 |
BAM
Berkshire Asset Management
Wilkes Barre,
Pennsylvania
|
-$597K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$79.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.29K |
CPIX Hedge Fund Activity: Q2 2020 in Review
30 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2020, worth a combined $13.8M — down 19% from $17M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CPIX positions and 2 closed out — a net gain of 4 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $465K. The largest seller was Ariel Investments, cutting an estimated $1.1M.
- 30 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2020, up from 26 in Q1 2020.
- Funds reported $13.8M of Cumberland Pharmaceuticals stock for Q2 2020, down 19% quarter-over-quarter.
- 6 funds opened new Cumberland Pharmaceuticals positions in Q2 2020 and 2 closed out, a net change of +4 holders.
- The largest Cumberland Pharmaceuticals buyer in Q2 2020 was Renaissance Technologies, an estimated $465K added.
- The largest Cumberland Pharmaceuticals seller in Q2 2020 was Ariel Investments, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2020.